ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0507

Gut Microbe Metabolite Short-Chain Fatty Acids May Associate with Development of Respiratory Involvement in Patients with Relapsing Polychondritis

Jun Shimizu1, Masanori Murayama2, Yoshishige Miyabe1 and Noboru Suzuki3, 1St. Marianna University School of Medicine, Kawasaki, Japan, 2Kansai Medical University, Hirakata, Japan, 3St. Marianna University School of Medicine, Kawasaki Kanagawa, Japan

Meeting: ACR Convergence 2022

Keywords: Cartilage Degradation, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Abstracts: Miscellaneous Rheumatic and Inflammatory Diseases I

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Relapsing polychondritis (RP) is an inflammatory disease that affects cartilaginous tissues of the body and the clinical manifestations and disease courses vary considerably among patients. We previously reported that auricular involvement and respiratory involvement were mutually exclusive in the incidence (Arthritis Rheumatol. 2018, Medicine. 2018). Serum MMP3 concentrations correlated with IL1β and IL6 mRNA expressions of peripheral blood mononuclear cells (PBMCs) only in RP patients with respiratory involvement (ACR Open Rheumatol. 2021). We further found that a short-chain fatty acid (SCFA) propionate-producing gut microbes increased in the intestine of RP patients compared with healthy individuals (Plos One. 2018). SCFAs were suggested to affect systemic inflammation through regulation of T cell differentiation in mouse models. Based on these data, in the current study, we compared bacterial abundance and gene functions between RP patients with and without respiratory involvement using software QIIME and LEfSe.

Methods: Metagenomic analysis of the gut microbiome was performed by sequencing of 16S rRNA gene in 21 RP patients. In the patients, 11 patients (52%) had respiratory involvement (termed as Resp group and other 10 patients were termed as Non-resp group). We extracted mRNA from freshly isolated and cultured PBMCs and measured a panel of cytokine gene expressions. We next evaluated serum MMP3 using an ELISA kit.

Results: No significant differences were observed in age, age at onset, gender, and disease duration between Resp and Non-resp groups. In the metagenomic analyses, we did not find significant differences in the OTU numbers and alpha diversity indexes between the two groups. In Non-resp group, family Veillonellaceae, family Ruminococcaceae, species Bifidobacterium bifidum, and species Faecalibacterium prausnitzii, all of which were reported to associate with SCFA production, were prevalent in the intestine. Family Leuconostocaceae and species Streptococcus anginosus were predominant in the bacterial composition of Resp group. As expected, bacterial gene functions of a SCFA butyrate synthesis pathway were prevalent in gut microbes of Non-resp group. We did not find any significant correlations among relative abundance of bacterial taxa, PBMC cytokine mRNA expressions, and serum MMP3.

Conclusion: These data suggest that the characteristic composition of gut microbes, probably through their production of SCFAs, may associate with not only disease onset but also progression processes of RP. Further, from the data of gut bacterial gene function, we speculate that each SCFA, propionate and butyrate, may be distinctively associated with clinical phenotypes of RP.


Disclosures: J. Shimizu, None; M. Murayama, None; Y. Miyabe, None; N. Suzuki, None.

To cite this abstract in AMA style:

Shimizu J, Murayama M, Miyabe Y, Suzuki N. Gut Microbe Metabolite Short-Chain Fatty Acids May Associate with Development of Respiratory Involvement in Patients with Relapsing Polychondritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/gut-microbe-metabolite-short-chain-fatty-acids-may-associate-with-development-of-respiratory-involvement-in-patients-with-relapsing-polychondritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbe-metabolite-short-chain-fatty-acids-may-associate-with-development-of-respiratory-involvement-in-patients-with-relapsing-polychondritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology